You are here: Home » PTI Stories » National » News
Business Standard

Pancreatic cancer accelerated by stress: study

Press Trust of India  |  New York 

accelerates the development of pancreatic by triggering the release of "fight-or- flight" hormones, a study has found.

Beta-blockers - commonly used medications that inhibit these hormones - were found to increase survival in a mouse model of the disease, said researchers at the Columbia University Medical Center in the US.

An additional analysis of patients with advanced pancreatic revealed that those who were taking beta- blockers for another condition lived about two-thirds longer than those who were not taking the medications.

Recent studies have shown that emotional and psychological play a role in the development of in general.

This effect is thought to occur through the sympathetic nervous system, which releases hormones that give the body a surge of so that it can respond to perceived dangers.

"Some biologists dismissed this idea because is hard to measure," said Timothy C Wang, from the Columbia University Medical Center.

"Others wondered how could possibly be related to a biological process that involves DNA mutations and the growth of cells within a particular organ, such as the pancreas," Wang said.

The current study, published in the journal Cell, was designed to find the links between and early development of pancreatic

The researchers studied mice that are genetically predisposed to developing abnormal growths in the

The mice were raised in stressful living conditions (confined to a small space), control mice were raised in normal housing. After 14 weeks, 38 per cent of the stressed mice were found to have neoplastic pancreatic lesions, a precursor to pancreatic No such lesions were observed in the controls.

"We know that you need a DNA mutation to start on the path to cancer, but our findings suggest that is doing something to move things along," said Wang.

That "something" was the subject of a subsequent experiment. Studies of the mice revealed that increases levels of catecholamines - the fight-or-flight hormones - in the bloodstream.

"In other words, sets up what we call a feed- loop between nerves and cells that promotes development," said Wang.

In experiments with a different mouse model of pancreatic cancer, the researchers demonstrated that treating mice with and beta-blockers lived significantly longer than mice treated with alone.

They also looked at survival in 631 patients who had to treat advanced pancreatic between 2002 and 2013.

Those who were taking non-selective beta-blockers after had a median survival of 40 months, about two-thirds longer than patients taking selective beta-blockers, which affect fewer targets in the body, or neither type of beta- blocker.

(This story has not been edited by Business Standard staff and is auto-generated from a syndicated feed.)

First Published: Fri, January 12 2018. 13:00 IST